Artificial Organs Биоинженерия

Association Between the Pre‐Implant “I Need Help” Score and Survival After Left Ventricular Assist Device Implantation: A Retrospective Single‐Center Study

Naoki Arima, Dominik Berliner, Fatimah Merzah, Ali Merzah, Aiste Monika Jakstaite, Günes Dogan, Jasmin S. Hanke, Udo Bavendiek, Samira Soltani, Sara Knigge, Bastian Schmack, Dietmar Böthig, Arjang Ruhparwar, Johann Bauersachs, Jan D. Schmitto
Wiley · 2026-11-17 · DOI 10.1111/aor.70283

Аннотация

ABSTRACT Background The “I Need Help” score is a tool to facilitate referral of patients with advanced heart failure (HF). Although its prognostic value has been demonstrated in chronic HF, evidence regarding patients undergoing durable left ventricular assist device (LVAD) implantation remains limited. Methods This retrospective cohort study included patients with advanced HF who underwent durable LVAD implantation at a tertiary HF center between January 2018 and December 2019. The pre‐implant “I Need Help” score was calculated, and patients were stratified into higher‐score (≥ 6) and lower‐score (< 6) groups. The primary endpoint was all‐cause mortality during LVAD support. Survival was assessed using Kaplan–Meier and Cox proportional hazards models. Results Among 93 patients analyzed (median age, 59 years), 64 (68.8%) had a score ≥ 6. The higher‐score group had a more advanced disease stage, reflected by a higher prevalence of INTERMACS profiles 1–3. During the follow‐up, 63 patients died and nine underwent heart transplantation. The higher‐score was associated with increased mortality in univariable analysis (hazard ratio [HR] 2.05, 95% confidence interval [CI] 1.13–3.73, p = 0.018), but the association was attenuated after multivariable adjustment (adjusted HR, 1.76; 95% CI, 0.71–4.33; p = 0.221). Conclusions Patients with a higher pre‐implant “I Need Help” score had worse unadjusted survival after LVAD implantation, but this association was attenuated after adjustment. The score may reflect the cumulative burden of advanced HF features, although its independent prognostic value in LVAD recipients remains uncertain. These findings are hypothesis‐generating and require validation in larger cohorts.

Читать у издателя →